Video

Australia's R&D Incentive: Not A Gift, But A Tax Strategy

Source: Clinical Leader

Mike Burfield explains that the 43.5% R&D incentive is often misunderstood as free money. In reality, it’s a tax program requiring eligible entities, deductible R&D spend, and clear paths to revenue. Foreign sponsors must align tax, corporate, and transfer-pricing rules to benefit.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader